Sharpless: NCI paylines to drop amid continuing resolution and federal budget uncertainty

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI is temporarily reducing its paylines as the federal government is being funded at FY2021 levels via another continuing resolution, delaying the budgeting process for most federal agencies in the new fiscal year.

The paylines for R01 grants for established and new investigators are being lowered from the 11th percentile to the 9th percentile. Also, non-competing grants are getting a 10% cut for as long as Congress remains in turmoil over FY22 funding priorities.

“This year, the first CR was funded through Dec. 3, and that CR is now expired,” NCI Director Ned Sharpless said at a joint advisory board meeting Dec. 8. “We are into a second CR that, as I said, goes through Feb. 18, that pretty much assures that we’ll have budgetary uncertainty for more than 100 hundred days this fiscal year and perhaps longer than that. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login